Lupus Clinical Trials in New York

Showing 141-160 of 239 trials

FLARE Lupus Research Study Systemic Lupus Erythematosus

NCT03426384

The first phase of this pilot study will assess changes in quality of life at the end of a 16-week Mymee program in patients with moderate to severe SLE. The second phase will assess changes in healthcare utilization and cost over a one year period after program end.

System; Lupus Erythematosus

Mymee Inc.50 participantsStarted Feb 2018

New York, New York, United States

COMPLETEDPhase 2< 1 mile

A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus

NCT02725515

The purpose of this study is to determine the ability of XmAb5871 to maintain Systemic Lupus Erythematosus (SLE) disease activity improvement achieved by a brief course of disease-suppressing steroid therapy

Systemic Lupus Erythematosus

Xencor, Inc.105 participantsStarted Feb 2016

La Jolla, California, United States • Loma Linda, California, United States • San Leandro, California, United States +20 more locations

FLARE Lupus Research Study Systemic Lupus Erythematosus

A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus

Lupus Trials in Other Cities

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN)

Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)

Clinical Validation of New Commercial Sleep Monitoring Devices

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea

Evaluation of Vestibular Stimulation to Help Occasional Sleeplessness

Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus

A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Dex as Analgesic Adjuvant in OSA Patients

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

SNORE (Smartphone Analyses of Nocturnal Obstruction by Respiratory Evaluation) SOUNDS

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

Other Conditions in New York